These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8908074)

  • 21. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
    Cai J; Terasaki PI; Anderson N; Lachmann N; Schönemann C
    Transplantation; 2009 Jul; 88(2):226-30. PubMed ID: 19623018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress in understanding humoral rejection in kidney transplantation: implications for patient management.
    Pascual MA; Crespo M; Tolkoff-Rubin N
    Nefrologia; 2001; 21(4):327-31. PubMed ID: 11816504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitisation and post-transplant course after the implantation of ventricular assist device.
    Malickaite R; Rucinskas K; Staneviciene A; Miniauskas S; Maneikiene V; Zuoziene G; Sirvydis V
    Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):339-42; discussion 342-3. PubMed ID: 19098066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal testing of seventy-six renal allograft patients for HLA antibodies: Maastricht experience.
    van den Berg-Loonen EM; Terasaki P; Kohanof S; Christiaans MH
    Clin Transpl; 2006; ():305-22. PubMed ID: 18365386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal testing of 266 renal allograft patients for HLA and MICA antibodies: Greenville experience.
    Ozawa M; Rebellato LM; Terasaki PI; Tong A; Briley KP; Catrou P; Haisch CE
    Clin Transpl; 2006; ():265-90. PubMed ID: 18365384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detailed examination of HLA antibody development on renal allograft failure and function.
    Zhu L; Lee PC; Everly MJ; Terasaki PI
    Clin Transpl; 2008; ():171-87. PubMed ID: 19711514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay.
    Billen EV; Christiaans MH; Lee J; van den Berg-Loonen EM
    Transplantation; 2009 Feb; 87(4):563-9. PubMed ID: 19307795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidonor-HLA antibodies and soluble HLA antigens after kidney transplant.
    Piazza A; Torlone N; Valeri M; Poggi E; Monaco PI; Provenzani L; Tisone G; Adorno D; Casciani CU
    Transplant Proc; 1993 Dec; 25(6):3279-80. PubMed ID: 8266542
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of antibody-mediated kidney transplant rejection.
    Morath C; Opelz G; Zeier M; Süsal C
    Transpl Int; 2012 Jun; 25(6):633-45. PubMed ID: 22587522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation.
    Ferrari-Lacraz S; Berney T; Morel P; Marangon N; Hadaya K; Demuylder-Mischler S; Pongratz G; Pernin N; Villard J
    Transplantation; 2008 Jul; 86(2):357-9. PubMed ID: 18645502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.
    Seveso M; Bosio E; Ancona E; Cozzi E
    Contrib Nephrol; 2009; 162():87-98. PubMed ID: 19001816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitization after kidney transplantation.
    Akalin E; Pascual M
    Clin J Am Soc Nephrol; 2006 May; 1(3):433-40. PubMed ID: 17699242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
    Aubert V; Venetz JP; Pantaleo G; Pascual M
    Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Summary of the effect of de novo HLA antibodies on chronic kidney graft failure.
    Terasaki P; Lachmann N; Cai J
    Clin Transpl; 2006; ():455-62. PubMed ID: 18365403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Graft loss associated with late humoral rejection after renal transplantation.
    Sun Q; Li L
    Clin Transpl; 2006; ():521-5. PubMed ID: 18365417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoadsorption with protein A in humoral acute rejection of kidney transplants: multicenter experience.
    Mastrangelo F; Pretagostini R; Berloco P; Poli L; Cinti P; Patruno P; Alfonso L; Pompei L; Carboni F; Rizzelli S
    Transplant Proc; 1995 Feb; 27(1):892-5. PubMed ID: 7879221
    [No Abstract]   [Full Text] [Related]  

  • 38. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful living donor kidney transplantation across HLA and ABO incompatibilities.
    Magee CC; Mah H; Tinckam K; Wood I; Ji F; Powelson J
    Nephrol Dial Transplant; 2007 Feb; 22(2):602-4. PubMed ID: 17132704
    [No Abstract]   [Full Text] [Related]  

  • 40. [Alloantibodies-mediated kidney transplant rejection: a pair of continuing approaches, and with nonetheless many open questions].
    Böhmig G
    Wien Klin Wochenschr; 2006 Jul; 118(13-14):373-81. PubMed ID: 16865640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.